A signal you already make
Your body already produces GHRH to prompt its own growth-hormone release. Tesamorelin is a stabilized version of that signal.
For the belly fat that won't take the hint.
Tesamorelin is studied specifically for visceral fat, the deep belly fat around your organs that is hardest to shift. Clinician-guided injections, personalized to you and delivered to your door.
From $127/ month
It is a stabilized version of a signal your body already uses to release its own growth hormone. Rather than adding synthetic hormone, it works with a system you already have.
Your body already produces GHRH to prompt its own growth-hormone release. Tesamorelin is a stabilized version of that signal.
It does not add HGH. It prompts your own pituitary to release growth hormone in its natural rhythm.
Your tesamorelin is prepared to your clinician's prescription by a US-licensed compounding pharmacy, under USP sterility standards. Your dose, your name on the vial.
People often ask whether tesamorelin competes with their weight-loss medication. It does not. They work through different pathways and are often considered together.
| Tesamorelin | GLP-1 (tirz / sema) | |
|---|---|---|
| Main focus | Visceral fat & body composition | Appetite & overall weight |
| How it works | Prompts your own growth hormone | Acts on appetite and blood sugar |
| Targets deep belly fat | Studied specifically for it | Reduces fat overall |
| Affects appetite | Not the primary effect | Yes, a core effect |
| Used together? | Often, under one clinician | Often, under one clinician |
Most of the peptide market blurs the line between biology, early research, and proven results. We would rather be clear with you.
Tesamorelin is an FDA-approved medication for a specific condition (HIV-associated lipodystrophy), where clinical trials showed it reduced visceral fat. Its biology and effect on visceral fat are well characterized.
Researchers have studied tesamorelin's effect on visceral fat and body composition in broader groups. Interest continues to grow in metabolic and healthy-aging contexts.
Using compounded tesamorelin for general body composition is off-label and not FDA-approved for that purpose. It affects the growth-hormone axis and can influence blood sugar, so it is not right for everyone. Your clinician decides.
Tesamorelin is FDA-approved for a specific condition. Using compounded tesamorelin for general body composition or weight-related goals is off-label and is not FDA-approved for that purpose. It is available by prescription only and is dispensed when a licensed clinician determines it is clinically appropriate. Not everyone is a candidate.
Tesamorelin acts on the growth-hormone axis and can affect blood sugar and fluid balance. It is generally not appropriate for people with active cancer, certain pituitary conditions, or during pregnancy or breastfeeding. Tell your Belle clinician about your full medical history, all medications including any GLP-1, and any diabetes or blood-sugar concerns.
This page is for general educational purposes and is not medical advice. Individual results vary. Do not start, stop, or change any treatment without talking to your provider. If you experience a serious reaction, seek medical care right away.
Take the short screening. A licensed clinician reviews your health history, your goals, and any current medications, then builds a protocol around you, or tells you plainly if tesamorelin is not the right fit.
Reviewed by US-licensed clinicians · Prescription required · Off-label, compounded use is not FDA approved
Tesamorelin from $127/moTakes about 5 minutes
Check eligibility